{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:41:46Z","timestamp":1776660106882,"version":"3.51.2"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The prerequisite for achieving the goal of the World Health Organization to completely eliminate viral hepatitis by 2030 is China\u2019s accurate understanding of the current disease burden, thereby providing a basis for formulating and optimizing intervention measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Based on the Global Burden of Disease (GBD) 2023 dataset, we extracted data on acute hepatitis A, B, C, and E in China, including incidence, mortality, disability-adjusted life years (DALYs), and their corresponding age-standardized rates (ASRs). To account for differences in age and sex distributions, we calculated ASRs based on the age-specific data extracted from the GBD 2023 dataset. To further assess temporal patterns across different age groups, we estimated the average annual percent change (AAPC). We applied the autoregressive integrated moving average model to project acute viral hepatitis (AVH) disease burden for 2024\u20132030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2023, there were an estimated 48.7 million incidence cases of AVH in China, including approximately 19.0 million cases of acute hepatitis A (AHA), 19.2 million cases of acute hepatitis B (AHB), 1.35 million cases of acute hepatitis C (AHC), and 9.2 million cases of acute hepatitis E (AHE). From 1990 to 2023, the overall age-standardized incidence rates (ASIR) of the four major AVH types in China declined (AAPC = \u22120.90%, 95% confidence interval [CI]: \u22120.93% to \u22120.87%). In the previous decade, divergent trends were observed. The ASIR of AHC increased (AAPC = 1.42%, 95% CI: 1.39\u20131.46%), AHE remained stable (AAPC = \u22120.04%, 95% CI: \u22120.39\u20130.32%), whereas AHA and AHB decreased. Moreover, the age-standardized mortality and DALYs rates for AVH significantly decreased. Age-specific analysis further revealed an upward trend in standardized incidence among individuals aged 25\u201329 years (AAPC = 0.14%, 95% CI: 0.10\u20130.19%). A continued decline in the ASIR of AVH is projected for 2024\u20132030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In China, the overall burden of AVH has decreased between 1990 and 2023. AHB vaccination among younger populations should be strengthened, and targeted prevention and control strategies should be implemented for those at high risk of AHC, to curb the spread of the disease and reduce the overall burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004010","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:00:10Z","timestamp":1773288010000},"page":"1191-1200","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["National trends in acute viral hepatitis in China from 1990\u20132023: An analysis of the Global Burden of Disease 2023 update"],"prefix":"10.1097","volume":"139","author":[{"given":"Jingran","family":"Jiao","sequence":"first","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"},{"name":"Department of Clinical Epidemiology and Clinical Trial, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Che","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jining No.1 People\u2019s Hospital, Jining, Shandong 272000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Wang","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingkun","family":"Song","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manman","family":"Xu","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing You\u2019an Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cld.2020.04.008","article-title":"Viral hepatitis other than A, B, and C: Evaluation and management","volume":"24","author":"Cheung","year":"2020","journal-title":"Clin Liver Dis"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","article-title":"Viral hepatitis update: Progress and perspectives","volume":"27","author":"Pisano","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00103-021-03478-8","article-title":"Epidemiologie der Virushepatitiden A bis E in Deutschland (in German)","volume":"65","author":"Dudareva","year":"2022","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tracli.2014.07.007","article-title":"Virus de l\u2019h\u00e9patite E, implications en transfusion sanguine (in French)","volume":"21","author":"Gallian","year":"2014","journal-title":"Transfus Clin Biol"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41426-018-0125-y","article-title":"Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors","volume":"7","author":"Wen","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s12072-022-10400-0","article-title":"New progress towards elimination of mother-to-child transmission of hepatitis B virus in China","volume":"16","author":"Zheng","year":"2022","journal-title":"Hepatol Int"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra2212151","article-title":"Hepatitis D virus infection","volume":"389","author":"Asselah","year":"2023","journal-title":"N Engl J Med"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S2468-1253(23)00321-7","article-title":"Progress towards elimination of viral hepatitis: A Lancet Gastroenterology & Hepatology Commission update","volume":"9","author":"Cooke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","article-title":"Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990\u20132019","volume":"75","author":"Zeng","year":"2021","journal-title":"J Hepatol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2468-2667(23)00149-4","article-title":"Hepatitis B and C in Europe: An update from the Global Burden of Disease Study 2019","volume":"8","year":"2023","journal-title":"Lancet Public Health"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jvh.13903","article-title":"International disease burden of acute viral hepatitis among adolescents and young adults: An observational study","volume":"31","author":"Yang","year":"2023","journal-title":"J Viral Hepat"},{"key":"R13-20260420","article-title":"Non-communicable disease burden in China, 1990\u20132023: Evidence from the Global Burden of Disease Study 2023","author":"Zhang","year":"2025","journal-title":"Chin Med J"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","article-title":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"R15-20260420","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078432","article-title":"Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: Population based study","volume":"385","author":"Yang","year":"2024","journal-title":"BMJ"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12072-024-10765-4","article-title":"Global, regional, and national temporal trends in incidence and mortality for liver cancer due to hepatitis B, 1990\u20132021: A decomposition and age-period-cohort analysis for the Global Burden of Disease Study 2021","volume":"19","author":"Li","year":"2024","journal-title":"Hepatol Int"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40249-022-01032-5","article-title":"Impact of the national hepatitis B immunization program in China: A modeling study","volume":"11","author":"Liu","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3201\/2302.161095","article-title":"Changing epidemiology of hepatitis A and hepatitis E viruses in China. 1990\u20132014","volume":"23","author":"Ren","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.31429","article-title":"Changing epidemiology of hepatitis A in China: Evidence from three national serological surveys and the national notifiable disease reporting system","volume":"73","author":"Wang","year":"2020","journal-title":"Hepatology"},{"key":"R22-20260420","doi-asserted-by":"crossref","DOI":"10.5210\/ojphi.v11i1.9897","article-title":"Systematic review: National notifiable infectious disease surveillance system in China","volume":"11","author":"Ren","year":"2019","journal-title":"Online J Public Health Inform"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1186\/s12913-020-05944-6","article-title":"The development of a legal framework for blood donation and blood safety in China over 24\u2009years","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12985-025-02907-3","article-title":"Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D","volume":"22","author":"Liu","year":"2025","journal-title":"Virol J"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CM9.0000000000001886","article-title":"Advances in the diagnosis and treatment of viral hepatitis B and C in China","volume":"135","author":"Jia","year":"2021","journal-title":"Chin Med J"},{"key":"R26-20260420","article-title":"Factors influencing immunologic response to hepatitis B vaccine in adults","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4161\/hv.24480","article-title":"Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen","volume":"9","author":"Rosenberg","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/vaccines13060621","article-title":"Vaccination strategies and research gaps in hepatitis E virus for special populations","volume":"13","author":"Wang","year":"2025","journal-title":"Vaccines"},{"key":"R29-20260420","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1476748","article-title":"Trends and projections of hepatitis A incidence in eastern China from 2007 to 2021: An age-period-cohort analysis","volume":"12","author":"Peng","year":"2024","journal-title":"Front Public Health"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1186\/s12889-024-20739-8","article-title":"Spatiotemporal characteristics and socioeconomic inequalities in water, sanitation, and hygiene access in China from 2000 to 2020: Analysis of data from three national censuses","volume":"24","author":"Li","year":"2024","journal-title":"BMC Public Health"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1017\/S0950268821001552","article-title":"Epidemiologic trends of hepatitis A in different age groups and regions of China from 1990 to 2018: Observational population-based study","volume":"149","author":"Zheng","year":"2021","journal-title":"Epidemiol Infect"},{"key":"R32-20260420","doi-asserted-by":"crossref","DOI":"10.2196\/70888","article-title":"Epidemic trends and spatial distribution characteristics of hepatitis B in China: Surveillance study","volume":"11","author":"Li","year":"2025","journal-title":"JMIR Public Health Surveill"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1097\/CM9.0000000000001791","article-title":"Elimination of hepatitis B virus infection in children: Experience and challenge in China","volume":"134","author":"Tang","year":"2021","journal-title":"Chin Med J"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/587695","article-title":"Humoral and cellular immune responses to a hepatitis B vaccine booster 15\u201318 years after neonatal immunization","volume":"197","author":"Lu","year":"2008","journal-title":"J Infect Dis"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/vaccines13020174","article-title":"Increasing prevalence of occult HBV infection in adults vaccinated against hepatitis B at birth","volume":"13","author":"Zhong","year":"2025","journal-title":"Vaccines"},{"key":"R36-20260420","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127408","article-title":"The HBV seroprevalence and immune responses to hepatitis B vaccination among college students from four universities in China","volume":"61","author":"Song","year":"2025","journal-title":"Vaccine"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12879-019-4091-3","article-title":"A retrospective serological survey of hepatitis B virus infection in Northeast China","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/0956462416688818","article-title":"Prevalence and the associated risk factors of HIV, STIs and HBV among men who have sex with men in Kunming, China","volume":"28","author":"Zhang","year":"2017","journal-title":"Int J STD AIDS"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/17513758.2021.1896797","article-title":"Modelling homosexual and heterosexual transmissions of hepatitis B virus in China","volume":"15","author":"Lu","year":"2021","journal-title":"J Biol Dyn"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12889-021-10408-5","article-title":"Evaluating the independent influence of sexual transmission on HBV infection in China: A modeling study","volume":"21","author":"Li","year":"2021","journal-title":"BMC Public Health"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.15585\/mmwr.mm7348a3","article-title":"Updated recommendation for universal hepatitis B vaccination in adults aged 19\u201359 years \u2014 United States, 2024","volume":"73","author":"Sandul","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"R44-20260420","first-page":"712","article-title":"Expert recommendations on hepatitis B vaccination in adults (in Chinese)","volume":"32","year":"2024","journal-title":"Chin J Hepatol"},{"key":"R45-20260420","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.70026","article-title":"Global burden and trends of acute hepatitis C from 1990 to 2021: An analysis based on the 2021 global burden of disease study","volume":"32","author":"Wang","year":"2025","journal-title":"J Viral Hepat"},{"key":"R46-20260420","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28353","article-title":"Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019","volume":"95","author":"Du","year":"2023","journal-title":"J Med Virol"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1186\/s12889-023-16756-8","article-title":"Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004\u20132018","volume":"23","author":"Luo","year":"2023","journal-title":"BMC Public Health"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/00952990.2011.643984","article-title":"The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China","volume":"38","author":"Bao","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.puhe.2008.01.014","article-title":"Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis","volume":"122","author":"Xia","year":"2008","journal-title":"Public Health"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12879-025-10778-w","article-title":"Epidemiological characteristics and spatiotemporal distribution of hepatitis C in southeast coastal areas of China from 2015 to 2022","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijid.2018.11.006","article-title":"Prevalence of hepatitis C virus infection among key populations in China: A systematic review","volume":"80","author":"Liu","year":"2018","journal-title":"Int J Infect Dis"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12879-018-2988-x","article-title":"Hepatitis B\/C in the countries of the EU\/EEA: A systematic review of the prevalence among at-risk groups","volume":"18","author":"Falla","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jgh.15827","article-title":"Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: A systematic review","volume":"37","author":"Goel","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 6","key":"R54-20260420","article-title":"Sexually transmitted hepatitis C virus infections: Current trends, and recent advances in understanding the spread in men who have sex with men","volume":"22","author":"Nijmeijer","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11920-019-1090-4","article-title":"Sexuality and the older adult","volume":"21","author":"Srinivasan","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/trstmh\/trab106","article-title":"HCV\/HIV coinfected Egyptian patients: A cross-sectional study of their main characteristics and barriers to HCV treatment initiation","volume":"116","author":"Eletreby","year":"2022","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R57-20260420","doi-asserted-by":"crossref","DOI":"10.2196\/35785","article-title":"Patterns of HIV or AIDS mortality among older people from 1990 to 2019 in China: Age-period-cohort analysis","volume":"8","author":"Ren","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"R58-20260420","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1594289","article-title":"Gonorrhoea among China\u2019s aging population: A 20-year nationwide analysis of epidemiological trends with 5-year projections","volume":"13","author":"Peng","year":"2025","journal-title":"Front Public Health"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/v16081337","article-title":"Update on hepatitis C vaccine: Results and challenges","volume":"16","author":"Garbuglia","year":"2024","journal-title":"Viruses"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/14760584.2025.2452955","article-title":"Towards an HCV vaccine: An overview of the immunization strategies for eliciting an effective B-cell response","volume":"24","author":"Costa","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.3748\/wjg.v27.i47.8081","article-title":"Present and future management of viral hepatitis","volume":"27","author":"Gonz\u00e1lez Grande","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/v15081725","article-title":"Hepatitis A virus and hepatitis E virus as food- and waterborne pathogens-transmission routes and methods for detection in food","volume":"15","author":"Nemes","year":"2023","journal-title":"Viruses"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44280-025-00080-4","article-title":"Hepatitis E virus: A foodborne pathogen of concern in China","volume":"3","author":"Wang","year":"2025","journal-title":"One Health Adv"},{"key":"R64-20260420","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1243408","article-title":"Prevalence of hepatitis E virus in China from 1997 to 2022: A systematic review and meta-analysis","volume":"11","author":"Cao","year":"2023","journal-title":"Front Public Health"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1016\/j.vaccine.2019.07.067","article-title":"Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control","volume":"37","author":"Chen","year":"2019","journal-title":"Vaccine"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","article-title":"Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Huang","year":"2024","journal-title":"Lancet"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amepre.2021.03.011","article-title":"Decreases in hepatitis C testing and treatment during the COVID-19 pandemic","volume":"61","author":"Kaufman","year":"2021","journal-title":"Am J Prev Med"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1186\/s12889-025-22305-2","article-title":"Evaluation of the impact of COVID-19 on hepatitis B in Henan Province and its epidemic trend based on Bayesian structured time series model","volume":"25","author":"Li","year":"2025","journal-title":"BMC Public Health"},{"key":"R70-20260420","article-title":"Retrospective analysis of hepatitis B seroprevalence and vaccination coverage in South India: Bridging laboratory evidence with literature trends","volume":"114","author":"Nair","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S2468-1253(20)30237-5","article-title":"Eliminating viral hepatitis in the COVID-19 era: Weighing challenge and opportunity","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R72-20260420","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004275","article-title":"The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection","volume":"6","author":"Pley","year":"2021","journal-title":"BMJ Glob Health"},{"key":"R73-20260420","doi-asserted-by":"crossref","DOI":"10.2196\/53982","article-title":"The effectiveness of national expanded program on immunization with hepatitis A vaccines in the Chinese mainland: Interrupted time-series analysis","volume":"10","author":"Ming","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1186\/s12889-024-19318-8","article-title":"Viral hepatitis in China during 2002\u20132021: Epidemiology and influence factors through a country-level modeling study","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Public Health"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:01:50Z","timestamp":1776657710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004010","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"2025-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}